Modulation of autoimmune diseases by nitric oxide

Immunologic Research

Volumn 22, Issue 1, 2000, Pages 1-19

  Singh, Vijay K ^a   Mehrotra, Shikhar ^a   Narayan, Prem ^a   Pandey, Chandra M ^a   Agarwal, Shyam S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Autoimmunity; Immunomodulation; Nitric oxide; Th1 Th2 cytokines

Indexed keywords

CYTOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AUTOIMMUNE DISEASE; CELL COMMUNICATION; CYTOTOXICITY; HUMAN; IMMUNOMODULATION; LEUKOCYTE ADHERENCE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; TH1 CELL; TH2 CELL; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

EID: 0002990446     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:22:1:1     Document Type: Review

References (102)

1. 1 Koshland DE: The molecule of the year. Science 1992;258:1861.
2. 2 Laskin JD, Heck DE, Laskin DL: Multifunctional role of nitric oxide on inflammation. Trends Endocrinol Metab 1994;5:377-382.
3. 3 Appleton I, Tomlinson A, Willoughby DA: Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv Pharmacol 1996;35: 27-78.
4. 4 Christopherson KS, Bredt DS: Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest 1997;100:2424-2429.
5. 5 Bogdan C: The multiplex function of nitric oxide in (auto) immunity. J Exp Med 1998;187:1361-1365.
6. 6 Niedbala W, Wei XQ. Piedrafita D, Xu D, Liew FY: Effect of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol 1999;29:2498-2505.
7. 7 Fang FC: Perspective series: host/ pathogen interactions: mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818-2825.
8. 8 Nathan CF, Hibbs JB Jr: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991;3:65-70.
9. 9 Vladutiu AO: Role of nitric oxide in autoimmunity. Clin Immunol Immunopathol 1995;76:1-11.
10. 10 Moncada S, Higgs A: The L-arginine-nitric oxide pathway. New Engl J Med 1993;329:2002-2012.
11. 11 Sorimachi K, Akimoto K, Hattori Y, Leiri T, Niwa A: Secretion of TNF-alpha, IL-8 and nitric oxide by macrophages activated with polyanions, and involvement of interferon gamma in the regulation of cytokine secretion. Cytokine 1999;11:571-578.
12. 12 Kolb H, Kolb-Bachofen V: Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 1998;19:556-561.
13. 13 Marletta MA: Nitric oxide synthase: structure and mechanism. J Biol Chem 1993;268:12,231-12,234.
14. 14 Michel T, Feron O: Nitric oxide synthase: which, where, how, and why? J Clin Invest 1997;100:2146-2152.
15. 15 Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
16. 16 Forstermann U, Kleinert H: Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol 1995;352:351-364.
17. 17 Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Silvio MD, Wang SC, Nakayama DK, Simmons R, Snyder SH, Billiar TR: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-3495.
18. 18 Guo FH, DeRaeve HR, Rice TW, Stuehr DJ, Thunnissen FBJM, Erzurum S: Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci 1995;92:7809-7813.
19. 19 Adams V, Krabbes S, Jiang H, Yu J, Rahmel A, Gielen S, Schuler G, Hambrecht R: Complete coding sequence of inducible nitric oxide synthase from human heart and skeletal muscle of patients with chronic heart failure. Nitric Oxide 1998;2:242-249.
20. 20 Teng B, Murthy KS, Kuemmerle JF, Grider JR, Sase K, Michel T, Makhlouf GM: Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. Am J Physiol 1998;275:G342-G351.
21. 21 Laing KJ, Grabowski PS, Belosevic M, Secombes CJ: A partial sequence for nitric oxide synthase from a goldfish (Carassius auratus) macrophage cell line. Immunol Cell Biol 1996;74:374-379.
22. 22 Lin AW, Chang CC, McCormick CC: Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5′-flanking region. J Biol Chem 1996;271: 11,911-11,919.
23. 23 Iwashina M, Hirata Y, Imai T, Sato K, Marumo F: Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. Eur J Biochem 1996;237:668-673.
24. 24 Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci 1990;87:682-685.
25. 2+-dependent inducible nitric oxide synthase from guinea-pig lung. Biochem J 1998;333:795-799.
26. 26 Marsden PA, Heng HHQ, Duff CL, Shi XM, Tsui LC, Hall AV: Localization of the human gene for inducible nitric oxide synthase (NOS2) to chromosome 17q11.2-q12. Genomics 1994;19:183-185.
27. 27. Robinson LJ, Weremowicz W, Morton C, Michael T: Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS III) gene. Genomics 1994;19:350-357.
28. 28 Park CS, Lee HS, Lee HY, Krishna G: An unprocessed pseudogene of inducible nitric oxide synthase gene in human. Nitric Oxide 1997;1:294-300.
29. 29 Hall AV, Antoniou H, Wang Y, Cheung AH, Arbus AM, Olsen SL, Lu WC, Kau CL, Marsden PA: Structural organization of the human neuronal nitric oxide synthase gene (NOS I). J Biol Chem 1994;269:33,082-33,090.
30. 30 Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J: Alternative splicing of human inducible nitric-oxide synthase mRNA. Tissue-specific regulation and induction of cytokines, J Biol Chem 1996;271:27,184-27,187.
31. 31 Ogura T, Yokoyama T, Fujisawa H, Kurashima Y, Esumi H: Structural diversity of neuronal nitric oxide synthase mRNA in the nervous system. Biochem Biophys Res Commun 1993;193:1014-1022.
32. 32 Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TR, Hutchinson NI, Mudgett JS: Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 1994;269:6765-6772.
33. 33 Miyahara K, Kawamoto T, Sase K, Yui Y, Toda K, Yang LX, Hattori R, Aoyama T, Yamamoto Y, Doi Y, Ogoshi S, Hashimo K, Kawai C, Sasayama S, Shizute Y: Cloning and structural characterizaton of human endothelial nitric oxide synthase gene. Eur J Biochem 1994;223: 719-726.
34. 34 Nathan C, Xie QW: Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13,725-13,728.
35. 35 Gnanapandithen K, Chen Z, Kau CL, Gorczynski RM, Marsden PA: Cloning and characterization of murine endothelial constitutive nitric oxide synthase. Biochem Biophys Acta 1996;1308:103-106.
36. 36 Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C: Cloning and characterisation of inducible nitric oxide synthase from mouse macrophages. Science 1992;256:225-228.
37. 37 Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992;267: 14,519-14,522.
38. 38 Hibbs JB Jr., Westenfielder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurray MP, Kushner JP, Samlowski W: Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992;89:867-877.
39. 39 Denis M: Tumor necrosis factor and granulocyte macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 1991; 49:380-387.
40. 40 Bertholet S, Tzeng E, Felly-Bosco E, Mauel J: Expression inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol 1999;65:50-58.
41. 41 Fossetta JD, Niu XD, Lunn CA, Zavodny PJ, Narula SK, Lundell D: Expression of human inducible nitric oxide synthase in Escherichia coli. FEBS Lett 1996;379: 135-138.
42. 42 Laubach VE, Garvey EP, Sherman PA: High-level expression of human inducible nitric oxide synthase in Chinese hamster ovary cells and characterization of the purified enzyme. Biochem Biophys Res Commun 1996;218:802-807.
43. 43 Lowenstein CJ, Dinerman JL, Snyder SH: Nitric oxide: a physiologic messenger. Ann Int Med 1994;120:227-237.
44. 44 Aymerich MS, Bengoechea-Alonso MT, Lopez-Zabalza MJ, Santiago E, Lopez Moratalla N: Inducible nitric oxide synthase (iNOS) expression in human monocytes triggered by beta-endorphin through an increase in cAMP. Biochem Biophys Res Commun 1998;245: 717-721.
45. 45 Fushiya S, Kishi Y, Hattori K, Batkhuu J, Takano F, Singab AN, Okuyama T: Flavonoids from Cleome droserifolia suppress NO production in activated macrophages in vitro. Planta Med 1999;65:404-407.
46. 46 Sunyer T, Rothe L, Jiang X, Osdoby P, Collin-Osdoby P: Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production via avian osteoclast-like cells. J Cell Biochem 1996;60:469-483.
47. 47 Trajkovic V, Badovinac V, Popadic D, Hadzic O, Stojkovic MM: Cell-specific effect of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression. Immunology 1997;92: 402-406.
48. 48 Kroncke KD, Fehsel K, Kolb-Bachofen V: Nitric oxide: cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide 1997;2:107-120.
49. 49 Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
50. 50 Dimmeler S, Haendeler J, Nehls M, Zeiher AM: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997;185:601-607.
51. 51 Okuda Y, Sakoda S, Shimoaka M, Yanagihara T: Nitric oxide induces apoptosis in mouse splenic T lymphocytes. Immunol Lett 1996;52: 135-138.
52. 52 Adams MR, Jessup W, Hailstones D, Celermajer DS: L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 1997;95:662-668.
53. 53 Whiss PA, Andersson RG, Srinivas U: Modulation of P-selectin expression on isolated human platelets by a NO donor assessed by a novel ELISA application. J Immunol Methods 1997;200:135-143.
54. 54 Duhe RJ, Evans GA, Erwin RA, Kirken RA, Cox GW, Farrar WL: Nitric oxide and thiol redox regulation of Janus kinase activity. Proc Nat Acad Sci USA 1998;95: 126-131.
55. 55 Chang RH, Lin Feng M-H, Lai W-H, Lai M-Z: Nitric oxide increased interleukin-4 expression in T-lymphocytes. Immunology 1997;90: 364-369.
56. 56 Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Schmitt E, Rude E, Germann T: The interleukin-12 subunit specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 1993;23:2202-2208.
57. 57 Habib A, Bernard C, Lebert M, Cerminon C, Esposito B, Tedgui A, Maclouf J: Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol 1997; 158:3845-3851.
58. 58 Yan L, Wang S, Rafferty SP, Wesley RA, Danner RL: Endogenously produced nitric oxide increases tumor necrosis factor-alpha production in transfected human U937 cells. Blood 1997;90:1160-1167.
59. 59 Diefenbach A, Schindler N, Donhauser E, Lorenz E, Lasky T, Mac Micking J, Rollinghoff M, Gresser I, Bogdan C: Type I Interferon (TFN alpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998;8:77-87.
60. 60 Mills CD, Stevens RB, Sutherland DE: Nitric oxide in autoimmunity and cell transplantation. Transplant Proc 1994;26:3348.
61. 61 Miesel R, Kurpisz M, Kroger H: Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NAPDH oxidase. Free Radie Biol Med 1996;20:75-81.
62. 62 Miesel R, Murphy MP, Kroger H: Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated level of tumor necrosis factor alpha in plasma. Free Radic Res 1996;25:161-169.
63. 63 Kroemer G, Martinez C: Cytokines and autoimmune disease. Clin Immunol Immunopathol 1991;61: 275-295.
64. 64 Kelly CJ, Gold DP: Nitric oxide in intestinal nephritis and other autoimmune diseases. Semin Nephrol 1999;19:288-295.
65. 65 Mulligan MS, Hevel JM, Marletta MA, Ward PA: Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci. USA 1991;88: 6338-6342.
66. 66 Taylor-Robinson A, Phillips RS, Severn A, Monacada S, Liew FY: The role of Th1 and Th2 cells in rodent malaria infection. Science 1993;260:1931-1934.
67. 67 Singh VK, Mehrotra S, Agarwal SS: The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol Res 1999;20:147-161.
68. 68 Corbett JA, McDaniell ML: Does nitric oxide mediate autoimmune destruction of beta cells? Possible therapeutic intervention in IDDM. Diabetes 1992;41:897-903.
69. 69 Corbett JA, Mikhael A, Shimuzu J, Fredrick K, Misko TP, McDaniel ML, Kanagawa O, Unanue ER: Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci USA 1993;90:8992-8995.
70. 70 Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, Pippen AM, Ruiz P, Wood ER, Gilkeson GS: The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice,and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994;179: 651-660.
71. 71 Cross AH, Keeling RM, Goorha S, San M, Rodi C, Wyatt PS, Manning PT, Misko TP: Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J Neuroimmunol 1996; 71:145-153.
72. 72 Ialenti A, Moncada S, Di Rosa M: Modulation of adjuvant arthiritis by endogenous nitric oxide. Br J Pharmacol 1993;110:701-706.
73. 73 McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM: Suppression of arthiritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-754.
74. 74 Farrell AJ, Blake DR, Palmer RMJ, Moncada S: Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheumatol Dis 1992;51:1219-1222.
75. 75 Gold DP, Schroder K, Powel HC, Kelly CJ: Nitric oxide and immunomodulation of experimental allergic encephalomyelitis. Eur J Immunol 1997;27:2863-2869.
76. 76 Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH, Steinman L: Inhibition of nitric oxide synthase for treatment of experimental autoimmun encephalomyelitis. J Immunol 1997;158: 2940-2946.
77. 77 Ding M, Zhang M, Wong JL, Rogers NE, Ignarro LJ, Voskuhl RR: Antisense knockdown of inducible nitric oxide synthase inhibits induction of autoimmune encephalomyelitis in SJL/J mice. J Immunol 1998;160:2560-2564.
78. 78 Kuschnaroff LM, Overbergh L, Sefriouni H, Sobis H, Vandeputte M, Waer M: Effect of staphylococcal entertoxin B on the development of experimental autoimmine encephalomyelitis: influence of cytokine and inducible nitric oxide synthase production. J Neuroimmunol 1999;99:157-168.
79. 79 Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H, Koprowski H: Prevention of autoimmune experimental allergic encephalomyelitis by targeting nitric oxide and peroxy-nitrite: implication for treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997;94:2528-2533.
80. 80 Kleemann R, Rothe H, Kolb-Bachofen V, Xie QW, Nathan C, Martin S, Kolb H: Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett 1993;328:9-12.
81. 81 Kroncke KD, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H: Activation of macrophages kills pancreatic syngeneic islet cells via arginine dependent nitric oxide generation. Bioehem Biophys Res Commun 1991;175:752-758.
82. 82 Rothe H, Kolb H: Strategies of protection from nitric oxide toxicity in islets inflammation. J Mol Med 1999;77:40-44.
83. 83 Sjoholm A: Interleukin-I and nitric oxide involved in the pathogenesis diabetes. Lakartidningen 1999;96:2338-2341.
84. 84 Welsh N, Eizirik DL, Sandler S: Nitric oxide and pancreatic beta cell destruction in insulin dependent diabetes mellitus: don't take NO for an answer. Autoimmunity 1994;18:285-290.
85. 85 Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA, Pipeleers DO, Bendtzen K, Hellerstrom C: Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994;93: 1968-1974.
86. 86 Gilkeson GS, Mudgett JS, Seldin MF, Ruiz P, Alexander AA, Misukonis MA, Pisetsky DS, Weinberg JB: Clinical and serologic manefestation of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med 1997;186: 365-373.
87. 87 Gates JC, Ruiz P, Alexander A, Pippen AM, Gilkeson GS: Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol 1997;83: 86-92.
88. 88 Gabbai FB, Boggiano C, Peter T, Khang S, Archer C, Gold DP, Kelly CJ: Inhibiton of inducible nitric oxide synthase intensifies injuries and functional deterioration in autoimmune interstitial nephritis. J Immunol 1997;159: 6266-6275.
89. 89 Faure JP: Autoimmunity in the retina. Curr Top Eye Res 1980;20: 215-302.
90. 90 Singh VK, Biswas S, Anand R, Agarwal SS: Experimental autoimmune uveitis as animal model for human posterior uveitis. Indian J Med Res 1998;107:53-67.
91. 91 Singh VK, Biswas S, Rai G, Agarwal SS: Immunomodulation in human and experimental uveitis: recent advances. Indian J Opthamol 1999;47:65-77.
92. 92 Hoey S, Grabowski PS, Ralston SH, Forrester JV, Liversidge J: Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through IFN-gamma-dependent mechanism. J Immunol 1997;159: 5132-5142.
93. 93 Behar-Cohen FF, Savoldelli M, Parel JM, Goureau O, Thillaye-Goldenberg B, Courtois Y, Pouliquen Y, de Kozak Y: Reduction of corneal edema in endotoxin-induced uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis. Invest Ophthalmol Vis Sci 1998;39:897-904.
94. 94 Allen JB, McGahan MC, Ferrell JB, Adler KB, Fleisher LN: Nitric oxide synthase inhibitors exhibits differential time-dependent effect on LPS-induced uveitis. Exp Eye Res 1996;62:21-28.
95. 95 Bellot JL, Palmero M, Garcia-Cabanes C, Espi R, Hariton C, Orts A: Additive effect of nitric oxide and prostaglandine-E2 synthesis inhibitors in endotoxin-induced uveitis in rabbit. Inflamm Res 1996;45:203-208.
96. 96 Steiner L, Kroncke KD, Fehsel K, Kolb-Bachofen V: Endothelial cells as cytotoxic effector cells: cytokine-activated rat islet endothelial cells lyse syngeneic islet cells via nitric oxide. Diabetologia 1997;40:155-165.
97. 97 Kroncke K-D, Brenner H-H, Rodriguez M-L, Noack E, Kolb H, Kolb-Bachofen V: Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide. Biochem Biophys Acta 1993;1182:221-229.
98. 98 Hausladen A, Privalle CT, Keng T, De Angelo J, Stamler JS: Nitrosative stress: activation of the transcription factor OxyR. Cell 1998;86: 719-729.
99. 99 Wei XQ. Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller D, Monacada S, Liew FY: Altered immune response in mice lacking inducible nitric oxide synthase. Nature 1995;375:408-411.
100. 100 Tian L, Lawrence DA: Metal-induced modulation of nitric oxide production in vitro by murine macrophages; lead, nickel, and cobalt utilize different mechanisms. Toxicol Appl Pharmacol 1996;141:540-547.
101. 101 van der Meide PH, de Labie MC, Botman CA, Aten J, Weening JJ: Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-exposed brown Norway rats. Cell Immunol 1995; 161:195-206.
102. 102 MacMicking J, Xie Q-W, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-350.